You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

62 Results
Guidelines and Advice
Status: Current
ID: GL-C50-27
Nov 2021
Guidelines and Advice
Status: Current
ID: GL-C50-09
Jun 2019
Drug
Other Name(s): Alkeran®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Jun 2019
Drug
Other Name(s): Vesanoid®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Jun 2019
Drug
Other Name(s): Thalomid®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Jun 2019
Drug
Other Name(s): Purinethol®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Jun 2019
Drug
Other Name(s): Lysodren®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Jun 2019
Drug
Other Name(s): Lanvis®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Jun 2019
Drug
Other Name(s): Zolinza®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Jun 2019
Drug
Other Name(s): Ninlaro™
Quick Link(s):
Drug Monograph, Patient Info Sheet
Jun 2019
Regimen
Cancer Type:
Endocrine, 
Adrenal
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
ODB - General Benefit
    mitotane
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
DOXOrubicin,
etoposide,
CISplatin,
mitotane
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Nov 2021
Regimen
Cancer Type:
Endocrine, 
Adrenal
Show More Show more tags
, Show Less Show fewer tags
Intent: Adjuvant
Funding:
ODB - General Benefit
    mitotane
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
mitotane
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Nov 2021

Pages